Jan-March 2021 CDER Meetings and Conferences
January
- Jan. 14 CDER Compliance Conference
- Jan. 26 Non-clinical Immunogenicity Assessment of Generic Peptide Products: Development, Validation, and Sampling
- Jan. 27 OTC Monograph Reform in the CARES Act: Safety Orders, Webinar
- Jan. 27 Public Meeting: Interim Assessment of the Program for Enhanced Review Transparency and Communication in the Biosimilar User Fee Act
- Jan. 29 Regulatory Perspectives for Development of Drugs for Treatment of NASH, Webinar
February
March
- Mar. 3-4 Drug Master File (DMF) and Drug Substance Workshop
- Mar. 8 Public Meeting on Patient-Focused Drug Development for Vitiligo
- Mar. 30-31 Oncology Therapy Development Workshop: Pivotal Steps and Avoiding Pitfalls for Start-ups